Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weidu Wuyou soft capsule
- Development stage
- Phase 3
- Lead developer
- Shandong Green Leaf Natural Medicine Research and Development
- Administration
- Oral
01
Overview
Weidu Wuyou soft capsule is a traditional Chinese medicine (TCM) or natural product developed by Shandong Green Leaf Natural Medicine Research and Development Co., Ltd., a subsidiary of Luye Pharma. It is indicated for the treatment of the common cold, specifically the "wind-heat pattern" (feng-re) in TCM terminology. The drug is formulated as a soft capsule and has been evaluated in Phase 3 clinical trials in China to assess its efficacy in shortening the duration of disease and fever, as well as relieving associated symptoms in adults with early-stage common cold.
- Brand names
- Weidu Wuyou
- Other names
- Weidu Wuyou ruanjiaonang
Beyond the preview
Go deeper on Weidu Wuyou soft capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Weidu Wuyou soft capsule.